NuCicer
NuCicer produces chickpeas using proprietary plant breeding technologies, developing non-GMO, high-protein chickpea varieties that enable farmers to offer enhanced products throughout the agri-food supply chain. Founded in 2019 and headquartered in Davis, United States, NuCicer has raised approximately $25.3M in Series A funding from investors including Leaps by Bayer, Bayer, Blue Horizon, Lever VC, Illumina…
Funding snapshot
About
NuCicer produces chickpeas using proprietary plant breeding technologies, developing non-GMO, high-protein chickpea varieties that enable farmers to offer enhanced products throughout the agri-food supply chain. Founded in 2019 and headquartered in Davis, United States, NuCicer has raised approximately $25.3M in Series A funding from investors including Leaps by Bayer, Bayer, Blue Horizon, Lever VC, Illumina Ventures, Rhapsody Venture Partners, and The House Fund. The company employs 25 people and uses advanced genomic selection and breeding techniques to develop chickpea varieties with significantly higher protein content and improved agronomic traits, addressing the growing demand for plant-based protein ingredients. NuCicer's high-protein chickpeas offer food manufacturers a sustainable, non-allergenic protein source that can improve the nutritional profile and cost-effectiveness of plant-based food products while supporting regenerative agriculture through chickpea's natural nitrogen-fixing capabilities.
Business model
Genomics > Applied Genomics > Agrigenomics,
Crop Tech > Farm Inputs > Plant Breeding > Technology Providers
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.